Enterogenous infection of Candida albicans in immunocompromised rats under severe acute pancreatitis.
暂无分享,去创建一个
[1] Xiaozhong Zheng,et al. The Intestinal Mucus Layer is a Critical Component of the Gut Barrier that is Damaged During Acute Pancreatitis , 2014, Shock.
[2] E. Mao,et al. Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai , 2014, BMC Infectious Diseases.
[3] N. Yapar. Epidemiology and risk factors for invasive candidiasis , 2014, Therapeutics and clinical risk management.
[4] Yin-Tie Jin,et al. Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model , 2013, Experimental and therapeutic medicine.
[5] M. Petzold,et al. Possible transmission of Candida albicans on an intensive care unit: genotype and temporal cluster analyses. , 2013, The Journal of hospital infection.
[6] Chunhui Yang,et al. Disruption of the intestinal mucosal barrier in Candida albicans infections. , 2013, Microbiological research.
[7] H. Xie,et al. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis. , 2013, European review for medical and pharmacological sciences.
[8] Qiong Zhang,et al. Genotypic distribution of Candida albicans in dental biofilm of Chinese children associated with severe early childhood caries. , 2012, Archives of oral biology.
[9] F. Chang,et al. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[10] G. Hua,et al. Early Gut Barrier Dysfunction in Patients with Severe Acute Pancreatitis: Attenuated by Continuous Blood Purification Treatment , 2010, The International journal of artificial organs.
[11] İ. Kaleli,et al. Molecular Analysis of Candida albicans Isolates from Clinical Specimens , 2010, Mycopathologia.
[12] U. Sonnenborn,et al. Yeasts in the gut: from commensals to infectious agents. , 2009, Deutsches Arzteblatt international.
[13] J. Perfect,et al. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[14] A. Levin,et al. Candida colonisation as a source for candidaemia. , 2009, The Journal of hospital infection.
[15] T. Kanbe,et al. Genotyping of Candida albicans by fragment analysis of microsatellites combined with 25S rDNA and RPS-based strategies. , 2009, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.
[16] B. Millar,et al. Frequency and distribution of group I intron genotypes of Candida albicans colonising critically ill patients , 2005, British journal of biomedical science.
[17] N. Akar,et al. Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness , 2004, Mycoses.
[18] E. Anaissie,et al. Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] K. Nishimura,et al. Molecular Characterization of New Clinical Isolates ofCandida albicans and C. dubliniensis in Japan: Analysis Reveals a New Genotype of C. albicans with Group I Intron , 2001, Journal of Clinical Microbiology.
[20] D. Stevens,et al. Molecular and Phenotypic Characterization of Genotypic Candida albicans Subgroups and Comparison withCandida dubliniensis and Candida stellatoidea , 1999, Journal of Clinical Microbiology.
[21] E. Anaissie,et al. Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans , 1996, Antimicrobial agents and chemotherapy.
[22] P. Nyström,et al. Bacterial translocation during acute pancreatitis in rats. , 1993, The European journal of surgery = Acta chirurgica.